pharma-company /Medicinal products /Active ingredients

Rx · PZN 11349622

ZERBAXA 1 g-0,5 g powder for a concentrate for preparation of an infusion solution

German trade nameZERBAXA 1 g-0,5 g Pulver für einer Konzentrat zur Herstellung einer Infusionslösung

Active ingredientCeftolozane and beta-lactamase inhibitorSubstance (DE)Ceftolozan und Beta-Lactamase-Inhibitoren

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

N/A

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.


ZERBAXA 1 g-0,5 g powder for a concentrate for preparation of an infusion solution contains the active ingredient Ceftolozane and beta-lactamase inhibitor (German Ceftolozan und Beta-Lactamase-Inhibitoren). One pack size is recorded (PZN 11349622). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.


ZERBAXA 1 g-0,5 g powder for a concentrate for preparation of an infusion solution was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. No purchase price is available to us for this product.